Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01728844 · ClinicalTrials.gov registry record · NA
GUIDOR® Growth Factor Enhanced Bone Graft Substitute for the Treatment of Periodontal Defects 6-months Post-Surgery
A NA study, sponsored by Sunstar Americas.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
NCT01728844 is a NA study that has completed, run by Sunstar Americas. The registered enrollment target is 88 participants.
The verdict
NCT01728844, a NA study, has completed, sponsored by Sunstar Americas.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
Study Summary
GUIDOR Growth Factor Enchanted Bone Graft Substitute (GFeBGS) when used in periodontal surgery will shown greater gum and bone regeneration when compare to bone graft substitute alone. Also, to find the optimal dose.
Interventions
- DEVICE beta-tricalcium phosphate alone
- DEVICE GFeBGS 0.1%
- DEVICE GFeBGS 0.3%
- DEVICE GFeBGS 0.4%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2012-10 |
| Est. Completion | 2014-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01728844
The ClinicalTrials.gov registry entry for NCT01728844 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sunstar Americas, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which beta-tricalcium phosphate alone is the first listed.
NCT01728844 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01728844 about?
NCT01728844 is a clinical study titled "GUIDOR® Growth Factor Enhanced Bone Graft Substitute for the Treatment of Periodontal Defects 6-months Post-Surgery". GUIDOR Growth Factor Enchanted Bone Graft Substitute (GFeBGS) when used in periodontal surgery will shown greater gum and bone regeneration when compare to bone graft substitute alone. Also, to find the optimal dose.
What is the current status of trial NCT01728844?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2012-10. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01728844?
The interventions under investigation include: beta-tricalcium phosphate alone (DEVICE), GFeBGS 0.1% (DEVICE), GFeBGS 0.3% (DEVICE), GFeBGS 0.4% (DEVICE).
Who is sponsoring clinical trial NCT01728844?
This trial is sponsored by Sunstar Americas, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.